Tag: Pathology

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

Wearable Device Samples User’s Blood to Spot Cancer Cells

Circulating tumor cells (CTCs) cause metastases of cancer, but they might have a redeeming quality if we could use them as biomarkers for those very cancers. For most neoplasms, biopsies are performed to definitively diagnose the disease, but circulating tumor cells offer the possibility of “liquid biopsies” that only require the sampli (Read more...)

CRISPR-Chip Can Detect Genetic Mutations Within Minutes

Researchers at the University of California, Berkeley and the Keck Graduate Institute of The Claremont Colleges have developed a hand-held device that can detect genetic mutations, such as those causing genetic diseases or affecting how people respond to certain drugs, in just minutes. The device employs a combination of CRISPR and graphene transis (Read more...)

Microfluidic Device Measures Platelet Health in Minutes

Platelets are an important component of blood’s clotting mechanism. When platelets are not aggregating as well as they should, there might be a need for a platelet transfusion during clinical care. Platelet functionality is hard to determine quickly with current methods, but researchers at the University of Washington have developed a microfl (Read more...)

Diagnosing Esophageal Cancer More Accurately: Interview with Mark Rutenberg, CEO of CDx Diagnostics

Cancer of the esophagus is often related to chronic heartburn, something patients too often end up ignoring. The onset of the potentially deadly disease can be detected, though, given good enough imaging and regular screenings. The imaging component, that we’re particularly interested in, relies on physicians to take biopsies of random bits o (Read more...)

Blood Test for Early Stage Cancer Diagnosis: Interview with Dr. Van Etten, CMO of Laboratory for Advanced Medicine

The Laboratory for Advanced Medicine (LAM), a biotechnology company headquartered in the US, offers non-invasive, early stage cancer detection tests that will use the IvyGene Platform. These IvyGene tests are based on detecting genomic DNA shed by cancer cells into the blood stream. By assessing cell-free DNA found in blood samples, the company can (Read more...)